Donor stem cell transplant tested against standard care for myeloma relapse
Disease control
Terminated
This study looked at whether a stem cell transplant from a healthy donor could help people with multiple myeloma whose cancer came back after initial treatment. It compared this approach to continuing with standard drug therapy. The trial was stopped early and included 28 adults …
Phase: PHASE3 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC